Schrödinger, Inc.
SDGR

$1.41 B
Marketcap
$19.44
Share price
Country
$0.14
Change (1 day)
$38.00
Year High
$16.67
Year Low

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

marketcap

Schrödinger, Inc. (SDGR) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2023 89.12 M -27,433,000 254.4 M 802.96 M 567.8 M
2022 69.09 M 26.02 M 240.68 M 688.59 M 533.99 M
2021 40.55 M -40,398,000 199.4 M 756.49 M 625.06 M
2020 35.38 M -190,532,000 122.24 M 746.26 M 682.98 M
2019 25.74 M -11,514,000 248.59 M 155.27 M 118.54 M